MX2021012709A - Sistema terapeutico transdermico. - Google Patents

Sistema terapeutico transdermico.

Info

Publication number
MX2021012709A
MX2021012709A MX2021012709A MX2021012709A MX2021012709A MX 2021012709 A MX2021012709 A MX 2021012709A MX 2021012709 A MX2021012709 A MX 2021012709A MX 2021012709 A MX2021012709 A MX 2021012709A MX 2021012709 A MX2021012709 A MX 2021012709A
Authority
MX
Mexico
Prior art keywords
therapeutic system
transdermal therapeutic
sensitive adhesive
pressure sensitive
backing layer
Prior art date
Application number
MX2021012709A
Other languages
English (en)
Inventor
Florian Hammes
Tobias Kleudgen
Anja Tomeleri
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP19169726.7A external-priority patent/EP3725306A1/en
Priority claimed from US16/386,458 external-priority patent/US11752114B2/en
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of MX2021012709A publication Critical patent/MX2021012709A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un sistema terapéutico transdérmico, que comprende una capa de soporte, que no es permeable para el principio activo, y una capa matriz en un lado de la capa de soporte, en donde la capa matriz contiene por lo menos un adhesivo sensible a la presión y ketamina o una sal o solvato farmacéuticamente aceptable del mismo, en donde el por lo menos un adhesivo sensible a la presión tiene grupos hidroxilo libres, así como su uso como un medicamento, en particular para el tratamiento de depresión y dolor.
MX2021012709A 2019-04-17 2020-04-17 Sistema terapeutico transdermico. MX2021012709A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19169726.7A EP3725306A1 (en) 2019-04-17 2019-04-17 Transdermal therapeutic system
US16/386,458 US11752114B2 (en) 2019-04-17 2019-04-17 Transdermal therapeutic system
PCT/EP2020/060903 WO2020212596A1 (en) 2019-04-17 2020-04-17 Transdermal therapeutic system

Publications (1)

Publication Number Publication Date
MX2021012709A true MX2021012709A (es) 2022-01-24

Family

ID=70285704

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021012709A MX2021012709A (es) 2019-04-17 2020-04-17 Sistema terapeutico transdermico.

Country Status (10)

Country Link
US (1) US20220241218A1 (es)
EP (1) EP3955901A1 (es)
JP (1) JP7453994B2 (es)
KR (1) KR20210153667A (es)
CN (1) CN113710238A (es)
AU (1) AU2020257564B2 (es)
BR (1) BR112021019190A2 (es)
CA (1) CA3135552C (es)
MX (1) MX2021012709A (es)
WO (1) WO2020212596A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024067731A1 (zh) * 2022-09-30 2024-04-04 宜昌人福药业有限责任公司 S-氯胺酮经皮组合物及其制备方法和应用
WO2024067729A1 (zh) * 2022-09-30 2024-04-04 宜昌人福药业有限责任公司 S-氯胺酮经皮组合物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003201254A (ja) * 2001-12-28 2003-07-18 Hisamitsu Pharmaceut Co Inc 鎮痛剤活性増強剤の治療上有効な血中濃度を維持するための製剤
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US9370495B2 (en) * 2010-02-24 2016-06-21 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
CN103476404B (zh) * 2011-03-24 2017-09-29 帝国制药美国公司 包含活性剂层和活性剂转化层的透皮组合物
JP2012219044A (ja) * 2011-04-06 2012-11-12 Nitto Denko Corp 貼付製剤
PL2872126T3 (pl) * 2012-07-16 2018-06-29 Grünenthal GmbH Plaster farmaceutyczny do przezskórnego podawania tapentadolu
FI3054934T3 (fi) * 2013-10-07 2024-07-19 Teikoku Pharma Usa Inc Menetelmät ja koostumukset vieroitusoireyhtymien hoitoon käyttäen ei-sedatiivisia transdermaalisia deksmedetomidiinikoostumuksia
EP3206673B1 (en) * 2014-10-17 2024-08-21 Fidia Farmaceutici S.p.A. Dermal therapeutic system with high adhesivity
EP3297620A4 (en) 2015-06-27 2019-01-09 Shenox Pharmaceuticals, LLC TRANSDERMAL DELIVERY SYSTEM FOR KETAMINE
US20180064655A1 (en) * 2016-09-06 2018-03-08 Steven Sounyoung Yu Hydroxynorketamine Transdermal Patch
EP3528795A1 (de) * 2016-10-18 2019-08-28 LTS Lohmann Therapie-Systeme AG Zweischichtiges topisches therapeutisches system
KR20190060007A (ko) * 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
CA3059598A1 (en) 2017-04-20 2018-10-25 Guangzhou Dazhou Biomedicine Ltd. Transdermal drug delivery system for ketamine

Also Published As

Publication number Publication date
JP2022530345A (ja) 2022-06-29
US20220241218A1 (en) 2022-08-04
WO2020212596A1 (en) 2020-10-22
AU2020257564B2 (en) 2023-03-02
CA3135552A1 (en) 2020-10-22
EP3955901A1 (en) 2022-02-23
KR20210153667A (ko) 2021-12-17
AU2020257564A1 (en) 2021-10-28
CA3135552C (en) 2023-09-26
BR112021019190A2 (pt) 2021-11-30
JP7453994B2 (ja) 2024-03-21
CN113710238A (zh) 2021-11-26

Similar Documents

Publication Publication Date Title
IN2012DN01225A (es)
WO2011076621A3 (de) Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
ZA202202361B (en) Treatment of hidradenitis suppurativa using jak inhibitors
MX2021012709A (es) Sistema terapeutico transdermico.
MY183873A (en) Transdermal therapeutic system for application of an agent
ES2176234T3 (es) Sistema terapeutico transdermal con galantamina como componente activo.
MX2019007391A (es) Sistema terapeutico transdermico que contiene asenapina.
BR112015011729A2 (pt) dispositivo de perfusão adesivo de vários dias para administração transdérmica de rotigotina
MY163809A (en) Transdermal drug delivery system containing donepezil
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
MX2020000651A (es) Sistema de administracion transdermica con una membrana microporosa que tiene poros llenos de solvente.
MX2019007389A (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
PH12015502280A1 (en) Transdermal delivery system comprising donepezil or its salt
BR112019007325A2 (pt) sistema terapêutico tópico de duas camadas
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
WO2015126930A3 (en) Booster drug therapy for mycobacterium infections
WO2016149077A3 (en) Fentanyl transdermal delivery system
MX2020014286A (es) Sistema terapeutico transdermico que contiene asenapina.
WO2011066970A3 (de) Transdermales therapeutisches system für die verabreichung von peptiden
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
TW200719902A (en) Solid transdermal therapeutic system with uv absorber
AR108939A1 (es) Sistema de administración transdérmica que contiene metilfenidato o sus sales, y métodos de este